Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1984 1
1986 2
1987 2
1989 2
1990 1
1992 2
1993 1
1994 3
1995 14
1996 7
1997 15
1998 22
1999 30
2000 47
2001 43
2002 57
2003 76
2004 113
2005 113
2006 141
2007 174
2008 240
2009 267
2010 324
2011 365
2012 403
2013 451
2014 510
2015 509
2016 524
2017 512
2018 518
2019 524
2020 540
2021 370
Text availability
Article attribute
Article type
Publication date

Search Results

6,119 results
Results by year
Filters applied: . Clear all
Page 1
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020.
Park YJ, Choe YJ, Park O, Park SY, Kim YM, Kim J, Kweon S, Woo Y, Gwack J, Kim SS, Lee J, Hyun J, Ryu B, Jang YS, Kim H, Shin SH, Yi S, Lee S, Kim HK, Lee H, Jin Y, Park E, Choi SW, Kim M, Song J, Choi SW, Kim D, Jeon BH, Yoo H, Jeong EK; COVID-19 National Emergency Response Center, Epidemiology and Case Management Team. Park YJ, et al. Among authors: park sy. Emerg Infect Dis. 2020 Oct;26(10):2465-2468. doi: 10.3201/eid2610.201315. Epub 2020 Jul 16. Emerg Infect Dis. 2020. PMID: 32673193 Free PMC article.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial.
Blauvelt A, Leonardi C, Elewski B, Crowley JJ, Guenther LC, Gooderham M, Langley RG, Vender R, Pinter A, Griffiths CEM, Tada Y, Elmaraghy H, Lima RG, Gallo G, Renda L, Burge R, Park SY, Zhu B, Papp K; IXORA-R Study Group. Blauvelt A, et al. Among authors: park sy. Br J Dermatol. 2021 Jun;184(6):1047-1058. doi: 10.1111/bjd.19509. Epub 2020 Oct 25. Br J Dermatol. 2021. PMID: 32880909 Free PMC article. Clinical Trial.
Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling.
Son J, Cho JW, Park HJ, Moon J, Park S, Lee H, Lee J, Kim G, Park SM, Lira SA, Mckenzie AN, Kim HY, Choi CY, Lim YT, Park SY, Kim HR, Park SH, Shin EC, Lee I, Ha SJ. Son J, et al. Among authors: park sy. Cancer Immunol Res. 2020 Nov;8(11):1393-1406. doi: 10.1158/2326-6066.CIR-19-0828. Epub 2020 Sep 2. Cancer Immunol Res. 2020. PMID: 32878747
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
Youn JW, Hur SY, Woo JW, Kim YM, Lim MC, Park SY, Seo SS, No JH, Kim BG, Lee JK, Shin SJ, Kim K, Chaney MF, Choi YJ, Suh YS, Park JS, Sung YC. Youn JW, et al. Among authors: park sy. Lancet Oncol. 2020 Dec;21(12):1653-1660. doi: 10.1016/S1470-2045(20)30486-1. Lancet Oncol. 2020. PMID: 33271094 Clinical Trial.
Reducing bias in observational studies.
Park SY. Park SY. Korean J Anesthesiol. 2020 Aug;73(4):269-270. doi: 10.4097/kja.20348. Epub 2020 Jul 17. Korean J Anesthesiol. 2020. PMID: 32746540 Free PMC article. No abstract available.
6,119 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page